UGNEQ Financials 07/16/2014 10:36:36 Unigene Labo

UGNEQ Financials 07/16/2014 10:36:36
Unigene Laboratories, Inc.
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 9,438 20,508 11,340
Cost of Revenue 1,639 1,552 2,608
Gross Profit 7,799 18,957 8,732
Operating Expenses
Research and Development 5,311 9,016 6,428
Sales, General and Admin. 11,777 13,407 12,628
Non-Recurring Items - - -
Other - - -
Operating Income (9,371) (3,466) (10,324)
Income From Continuing Operations
Add'l Income/Expense Items (12,344) 6,253 (14,872)
Earnings Before Interest and Tax (21,689) 2,787 (25,196)
Interest Expense 13,858 10,484 8,039
Earnings Before Tax (35,547) (7,697) (33,234)
Income Tax (1,261) (601) (701)
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary (56) - -
Net Income Cont. Operations (34,343) (7,096) (46,915)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (34,286) (7,096) (32,534)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (34,286) (7,096) (32,534)